CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 88 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05055570
NCT05055570N/ACompleted

The Mechanism Research of Angiotensin II Pathway and Postoperative Hypoxemia

Beijing Anzhen Hospital·observational·Posted Sep 24, 2021·Updated Jan 26, 2024

In Brief

An observational study evaluating No intervention for Aortic Dissection. Completed, enrolled 88 participants across 1 site.

Detailed Summary

Acute type A aortic dissection is often accompanied by postoperative hypoxemia, the cause of which is not fully understood. Angiotensin II is an important component of the renin-angiotensin system (RAS), which has been suggested to be involved in the development of aortic dissection and pulmonary inflammation.The purpose of this study was to investigate the role and mechanism of angiotensin II pathway in postoperative hypoxemia after acute type A aortic dissection, and to provide reference for clinical application

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedSep 24, 2021
Enrollment StartAug 12, 2021
Primary CompletionJun 1, 2022
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 4.8 years ago

Interventions

No interventionother

No intervention